TP53 and acute myeloid leukemia: TP53 mutations are a strong indicator of prognosis, and studies have shown that, in AML, multi-hit mutated TP53 is associated with genomic instability, thrombocytopenia, and a higher blast count, independent of the VAF (Deng et al., 2020).